AstraZeneca posts another Truqap study fail, says China import tax could triplenews2025-04-29T10:37:06+00:00April 29th, 2025|Endpoints News|
WuXi AppTec sees revenue growth after 2024’s declinenews2025-04-28T17:20:03+00:00April 28th, 2025|Endpoints News|
Akeso reveals survival data for Keytruda-beating cancer drugnews2025-04-25T17:03:58+00:00April 25th, 2025|Endpoints News|
Drugmakers prepare for manageable tariff hit to business, earningsnews2025-04-24T18:28:14+00:00April 24th, 2025|Endpoints News|
Thermo Fisher buckles up for US-China trade war, budgets $2B to ease impactnews2025-04-24T10:45:23+00:00April 24th, 2025|Endpoints News|
Merck Q1 earnings: Gardasil sales hit by China market pressurenews2025-04-24T10:30:47+00:00April 24th, 2025|Endpoints News|
China’s biotech market is staging a comeback that US biotech can only wish fornews2025-04-23T14:00:55+00:00April 23rd, 2025|Endpoints News|
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffsnews2025-04-22T14:00:06+00:00April 22nd, 2025|Endpoints News|
China biotech startup HuidaGene uses CRISPR in brain for rare ailmentnews2025-04-21T15:00:57+00:00April 21st, 2025|Endpoints News|
China-based VelaVigo inks its second US biotech dealnews2025-04-17T19:00:02+00:00April 17th, 2025|Endpoints News|
